Loading...
XASX
HLS
Market cap347mUSD
Jul 04, Last price  
0.73AUD
1D
2.10%
1Q
-47.48%
Jan 2017
-81.45%
Name

Healius Ltd

Chart & Performance

D1W1MN
No data to show
P/E
—
P/S
0.30
EPS
—
Div Yield, %
—
Shrs. gr., 5y
1.67%
Rev. gr., 5y
2.20%
Revenues
1.75b
+2.30%
190,648,000240,716,000273,241,000649,641,0001,328,604,0001,286,822,0001,308,980,0001,390,880,0001,440,036,0001,524,115,0001,579,700,0001,641,900,0001,658,600,0001,704,600,0001,566,400,0001,557,000,0001,900,700,0002,288,900,0001,706,900,0001,746,200,000
Net income
-646m
L+72.40%
27,936,00047,480,00056,903,0006,777,000108,502,000131,997,00078,285,000116,615,000150,111,000114,553,000136,495,00038,400,000-516,799,9994,100,00055,900,000-70,500,00043,700,000307,900,000-374,600,000-645,800,000
CFO
267m
-12.92%
61,121,00059,549,00070,627,00051,999,000179,181,000225,043,000160,412,000228,705,000264,386,000260,740,000239,400,000285,100,000212,200,000202,200,000127,600,000380,200,000493,300,000573,800,000306,400,000266,800,000
Dividend
Sep 07, 20220.06 AUD/sh
Earnings
Aug 19, 2025

Profile

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through four segments: Pathology, Imaging, Day Hospitals, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. It also provides cataract surgery, colonoscopy, gastroscopy, plastic and cosmetic surgery, skin cancer removal, IVF egg collection, and gynaecological surgery services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetpath Laboratory, Vetnostics, QML Vetnostics, TML Vetnostics, ASAP Laboratory, Abbott Pathology, TML Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs; Lumus Imaging; and Montserrat brands. It operates 2,105 pathology sites; 11 day hospital sites; and 134 imaging sites. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
URL
https://www.healius.com.au/
IPO date
Jul 03, 1998
Employees
11,000
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑06
Income
Revenues
1,746,200
2.30%
1,706,900
-25.43%
Cost of revenue
2,136,400
1,612,000
Unusual Expense (Income)
NOPBT
(390,200)
94,900
NOPBT Margin
5.56%
Operating Taxes
(14,100)
(17,300)
Tax Rate
NOPAT
(376,100)
112,200
Net income
(645,800)
72.40%
(374,600)
-221.66%
Dividends
(34,300)
Dividend yield
1.75%
Proceeds from repurchase of equity
179,300
(5,200)
BB yield
-18.12%
0.27%
Debt
Debt current
271,300
263,000
Long-term debt
2,503,700
2,443,900
Deferred revenue
Other long-term liabilities
15,200
14,400
Net debt
2,711,700
2,584,500
Cash flow
Cash from operating activities
266,800
306,400
CAPEX
(50,900)
(76,100)
Cash from investing activities
(63,000)
67,300
Cash from financing activities
(259,000)
(339,700)
FCF
(348,100)
116,300
Balance
Cash
60,100
115,300
Long term investments
3,200
7,100
Excess cash
37,055
Stockholders' equity
1,040,700
1,506,200
Invested Capital
2,653,800
3,249,545
ROIC
3.25%
ROCE
2.89%
EV
Common stock shares outstanding
659,760
615,566
Price
1.50
-52.83%
3.18
-13.35%
Market cap
989,640
-49.44%
1,957,499
-16.59%
EV
3,701,340
4,541,999
EBITDA
(390,200)
372,100
EV/EBITDA
12.21
Interest
70,800
62,300
Interest/NOPBT
65.65%